These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 6891226)
21. Delayed-onset encephalopathy and coma in acute organophosphate poisoning in humans. Peter JV; Prabhakar AT; Pichamuthu K Neurotoxicology; 2008 Mar; 29(2):335-42. PubMed ID: 18304642 [TBL] [Abstract][Full Text] [Related]
22. Electromyographic identification of spinal oscillator patterns and recouplings in a patient with incomplete spinal cord lesion: oscillator formation training as a method to improve motor activities. Schalow G; Blanc Y; Jeltsch W; Zäch GA Gen Physiol Biophys; 1996 Aug; 15 Suppl 1():121-220. PubMed ID: 8934200 [TBL] [Abstract][Full Text] [Related]
23. Memantine (Ebixa) in clinical practice - results of an observational study. Calabrese P; Essner U; Forstl H Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714 [TBL] [Abstract][Full Text] [Related]
24. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Reisberg B; Doody R; Stöffler A; Schmitt F; Ferris S; Möbius HJ Arch Neurol; 2006 Jan; 63(1):49-54. PubMed ID: 16401736 [TBL] [Abstract][Full Text] [Related]
25. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Gauthier S; Wirth Y; Möbius HJ Int J Geriatr Psychiatry; 2005 May; 20(5):459-64. PubMed ID: 15852444 [TBL] [Abstract][Full Text] [Related]
26. The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: a study in the chronic porcine model. Rimpiläinen J; Pokela M; Kiviluoma K; Vainionpää V; Hirvonen J; Ohtonen P; Jäntti V; Anttila V; Heinonen H; Juvonen T J Thorac Cardiovasc Surg; 2001 May; 121(5):957-68; discussion 968-70. PubMed ID: 11326240 [TBL] [Abstract][Full Text] [Related]
27. Tinnitus treatment with memantine. Figueiredo RR; Langguth B; Mello de Oliveira P; Aparecida de Azevedo A Otolaryngol Head Neck Surg; 2008 Apr; 138(4):492-6. PubMed ID: 18359360 [TBL] [Abstract][Full Text] [Related]
28. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease. Grossberg GT; Pejović V; Miller ML; Graham SM Dement Geriatr Cogn Disord; 2009; 27(2):164-72. PubMed ID: 19194105 [TBL] [Abstract][Full Text] [Related]
29. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover. Quack G; Hesselink M; Danysz W; Spanagel R J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045 [TBL] [Abstract][Full Text] [Related]
30. Memantine therapy for Alzheimer disease in real-world practice: an observational study in a large representative sample of French patients. Vidal JS; Lacombe JM; Dartigues JF; Pasquier F; Robert P; Tzourio C; Alpérovitch A Alzheimer Dis Assoc Disord; 2008; 22(2):125-30. PubMed ID: 18525283 [TBL] [Abstract][Full Text] [Related]
31. Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial. Lindelof K; Bendtsen L Cephalalgia; 2009 Mar; 29(3):314-21. PubMed ID: 19220313 [TBL] [Abstract][Full Text] [Related]
32. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease. Wilkinson D; Andersen HF Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of memantine in community-based Alzheimer's disease patients: An adaptation in Spain. Antonanzas F; Rive B; Badenas JM; Gomez-Lus S; Guilhaume C Eur J Health Econ; 2006 Jun; 7(2):137-44. PubMed ID: 16670912 [TBL] [Abstract][Full Text] [Related]
34. [The EMG findings of spasmodic torticollis--the character of the EMG findings of neurogenic torticollis]. Ando T; Kayama T; Saito S; Kuroki A; Nakai O; Itagaki S No To Shinkei; 1997 Jul; 49(7):619-26. PubMed ID: 9234249 [TBL] [Abstract][Full Text] [Related]
35. [Semiologic, biochemical and electrophysiologic analysis of the stages of apopleptic coma]. Bogolepov NK; Fedin AI; Aristova RA; Dubrovskaia MK; Filippov MA Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(8):1127-37. PubMed ID: 973512 [TBL] [Abstract][Full Text] [Related]
36. Memantine enhances autonomy in moderate to severe Alzheimer's disease. Rive B; Vercelletto M; Damier FD; Cochran J; François C Int J Geriatr Psychiatry; 2004 May; 19(5):458-64. PubMed ID: 15156547 [TBL] [Abstract][Full Text] [Related]
37. [Memantine can relieve certain symptoms in Parkinson disease. Improvement achieved in two out of three described cases with dyskinesia and cognitive failure]. Lökk J Lakartidningen; 2004 Jun; 101(23):2003-6. PubMed ID: 15232837 [TBL] [Abstract][Full Text] [Related]